Braveheart Bio, Inc.

BRVE·NasdaqGM·Healthcare
Compare
20.11−1.29 (−6.01%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close21.39
Open21.54
Day range19.1621.56
52-week range17.8632.00
Off day high−6.75%
Off 52-week high−37.17%
Volume655.54K
Avg. volume (3M)477.40K
Market cap1.81B
EPS (TTM)-6.08
Forward P/E-10.10
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding90.04M
Short interest—
Earnings dateNov 12, 2026 (est.)
Analyst target45.25
Profit margin0.00%

Against its peers

Compare in full ›
BRVE SLDB EWTX KARD CYTK BHVN
Market cap 1.81B 699.11M 4.08B 1.45B 8.84B 2.30B
P/E (TTM) — — — — — —
Forward P/E -10.1 -3.8 -20.1 -3.8 -14.4 -8.2
Price/book -1.6 2.9 7.6 2.4 -11.9 -23.4
Dividend yield — — — — — —
1-year change −32.52% +54.69% +119.60% −29.27% +5.47% +78.66%
Today −6.01% +3.82% −0.40% +8.66% +2.07% −2.37%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All BRVE news ›

No recent coverage in the 4Search index.

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance